BRIEF-U.S. FDA Requests Labeling And Packaging Changes For OTC Loperamide

Jan 30 (Reuters) - U.S. Food and Drug Administration Commissioner Scott Gottlieb:

* STATEMENT FROM FDA COMMISSIONER SCOTT GOTTLIEB - FDA IS REQUESTING THAT SPONSORS OF OTC LOPERAMIDE CHANGE THE WAY THEY LABEL AND PACKAGE THESE DRUGS

* FDA’S GOTTLIEB - REQUESTING OTC MANUFACTURERS THAT PACKAGES CONTAIN LIMITED AMOUNT OF LOPERAMIDE APPROPRIATE FOR USE FOR SHORT-TERM DIARRHEA ACCORDING TO PRODUCT LABEL Source text for Eikon: